We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$228B
AUM Growth
-$15.4B
Cap. Flow
-$1.28B
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.8%
Holding
11,885
New
1,174
Increased
4,828
Reduced
3,849
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Financials 6.67%
3 Healthcare 6.52%
4 Consumer Discretionary 4.99%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNE
9751
DELISTED
Blue Horizon BNE ETF
BNE
$2K ﹤0.01%
80
-848
-91% -$20.3K
CVIIW
9752
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$2K ﹤0.01%
11,954
-481
-4% -$108
WKSPW
9753
DELISTED
Worksport, Ltd. Warrant
WKSPW
$2K ﹤0.01%
5,939
-516
-8% -$122
VBIV
9754
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$2K ﹤0.01%
112
SMLE
9755
DELISTED
Xtrackers S&P SmallCap 600 ESG ETF
SMLE
$2K ﹤0.01%
92
-38
-29% -$893
TRVN
9756
DELISTED
Trevena, Inc.
TRVN
$2K ﹤0.01%
26
-51
-66% -$7.82K
CLVRW
9757
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
$2K ﹤0.01%
33,397
+17,995
+117% +$2.33K
PETVW
9758
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$2K ﹤0.01%
4,715
+1,900
+67% +$606
AVHI
9759
DELISTED
Achari Ventures Holdings Corp I
AVHI
$2K ﹤0.01%
248
DWACU
9760
DELISTED
Digital World Acquisition Corp. Units
DWACU
$2K ﹤0.01%
90
-472
-84% -$13.9K
VJET
9761
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$2K ﹤0.01%
+692
New +$3.08K
LIAN
9762
DELISTED
LianBio American Depositary Shares
LIAN
$2K ﹤0.01%
+1,247
New +$2.98K
PHXM
9763
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$2K ﹤0.01%
432
-439
-50% -$4.35K
SLACW
9764
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$2K ﹤0.01%
9,159
+5,409
+144% +$1.73K
CHIH
9765
DELISTED
Global X MSCI China Health Care ETF
CHIH
$2K ﹤0.01%
162
-1,300
-89% -$20.7K
CHEAU
9766
DELISTED
Chenghe Acquisition Co. Unit
CHEAU
$2K ﹤0.01%
209
-2
-0.9% -$20
ORTX
9767
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2K ﹤0.01%
381
-5
-1% -$28
SALM
9768
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$2K ﹤0.01%
1,000
-6,921
-87% -$15.1K
SFE
9769
DELISTED
Safeguard Scientifics, Inc.
SFE
$2K ﹤0.01%
565
-8
-1% -$32
CHS
9770
DELISTED
Chicos FAS, Inc.
CHS
$2K ﹤0.01%
434
-179
-29% -$995
ENER
9771
DELISTED
Accretion Acquisition Corp
ENER
$2K ﹤0.01%
153
UFAB
9772
DELISTED
Unique Fabricating, Inc.
UFAB
$2K ﹤0.01%
4,128
-4,206
-50% -$3.94K
AAC.WS
9773
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$2K ﹤0.01%
15,174
+5,480
+57% +$939
CYTO
9774
DELISTED
Altamira Therapeutics Ltd
CYTO
$2K ﹤0.01%
20
-45
-69% -$7.47K
EAFD
9775
DELISTED
Simplify Developed Ex-US PLUS Downside Convexity ETF
EAFD
$2K ﹤0.01%
+115
New +$2.19K

Similar funds

UBS Group's Q3 2022 Portfolio in Review

As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2022 filing shows 1,174 new, 4,828 increased, 3,849 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
  • UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
  • UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
  • UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
  • UBS Group opened 1,174 new positions and closed 1,024 in Q3 2022.
  • UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.